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Abstract
Hypoxia is one of the features of poorly vascularised areas of solid tumours but cancer cells can survive in these areas
despite the low oxygen tension. The adaptation to hypoxia requires both biochemical and genetic responses that culminate
in a metabolic rearrangement to counter-balance the decrease in energy supply from mitochondrial respiration. The
understanding of metabolic adaptations under hypoxia could reveal novel pathways that, if targeted, would lead to specific
death of hypoxic regions. In this study, we developed biochemical and metabolomic analyses to assess the effects of
hypoxia on cellular metabolism of HCT116 cancer cell line. We utilized an oxygen fluorescent probe in anaerobic cuvettes to
study oxygen consumption rates under hypoxic conditions without the need to re-oxygenate the cells and demonstrated
that hypoxic cells can maintain active, though diminished, oxidative phosphorylation even at 1% oxygen. These results were
further supported by in situ microscopy analysis of mitochondrial NADH oxidation under hypoxia. We then used
metabolomic methodologies, utilizing liquid chromatography–mass spectrometry (LC-MS), to determine the metabolic
profile of hypoxic cells. This approach revealed the importance of synchronized and regulated catabolism as a mechanism
of adaptation to bioenergetic stress. We then confirmed the presence of autophagy under hypoxic conditions and
demonstrated that the inhibition of this catabolic process dramatically reduced the ATP levels in hypoxic cells and
stimulated hypoxia-induced cell death. These results suggest that under hypoxia, autophagy is required to support ATP
production, in addition to glycolysis, and that the inhibition of autophagy might be used to selectively target hypoxic
regions of tumours, the most notoriously resistant areas of solid tumours.
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Introduction
The majority of solid cancers contain poorly oxygenated areas
[1]. Cells react to oxygen limitation by genetic and biochemical
reprogramming that decrease mitochondrial functions and drives
glucose utilization for energy production [2]. The effects of oxygen
availability on the balance between oxidative phosphorylation and
glycolysis were observed more than a century ago by Louis Pasteur
[3]. It is now acknowledged that part of the adaptation to hypoxia
is mediated by numerous proteins among which the hypoxia
inducible transcription factor HIF1 plays a major role [4]. When
oxygen is limited HIF1a is stabilized and can bind to its partner
HIF1b to form an active HIF1 complex which induces its tar-
get genes and leads to a complex metabolic rearrangement
[5,6,7,8,9,10,11]. The effects of this rearrangement include the
upregulation of glycolytic enzymes and the glucose transporter
Glut1. In addition, HIF also regulates mitochondrial functions. It
was recently shown that HIF1 stabilization under hypoxia leads to
the expression of Pyruvate Dehydrogenase Kinase 1 (PDK1)
[7,10] a protein that phosphorylates and inactivates Pyruvate
Dehydrogenase (PDH), limiting the conversion of pyruvate to
Acetyl-CoA in the mitochondria. Consequently, PDK1 induction
decreases the tricarboxylic acid (TCA) cycle activity and reduces
oxygen consumption.
Hypoxia may thus affect energy metabolism both directly, by
limiting the availability of oxygen to the mitochondria, and
indirectly through transcription-mediated metabolic rearrange-
ments. Therefore, it is crucial to develop reliable techniques for
assessing mitochondrial functions under hypoxia. This is of
particular importance when looking for general cellular metabolic
changes imposed by low oxygen since the mitochondrion is a
complex metabolic hub that not only provides energy for the cell
but is also crucial for the generation of reducing equivalents
(NADH and NADPH) and building blocks for anabolic reactions
[12]. It is therefore reasonable to assume that hypoxic impairment
of mitochondria may have metabolic effects beyond anaerobic
glycolysis.
Metabolomics is a powerful tool developed to systematically
analyse the metabolic fingerprint of a cell, widely used in the past
to analyze microorganisms metabolism [13]. Metabolomic studies
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have shown that cellular metabolic networks are robust and the
dynamic behaviour of biochemical pathways is governed by a
highly interconnected regulatory system [14]. Our current
challenge is to understand how this robust system is deregulated
and perturbed under hypoxia and how this leads to a new
metabolic fingerprint. In this work, the effect of hypoxia on
cellular metabolism was analysed in HCT116 colorectal cancer
cell lines using a combination of biochemistry, microscopy and
metabolomics techniques. We demonstrated that these cells adapt
to hypoxia by increasing anaerobic glycolysis and by decreasing
respiratory rate and mitochondrial functions. The metabolomics
approach further unveiled unexpected metabolic signature that
demonstrated the importance of catabolic reactions for the
survival of hypoxic cells.
Results
Assessment of the hypoxic phenotype
The cellular response to hypoxia was studied by culturing
HCT116 (ATCCH Number: CCL-247TM) cells either under
normoxia (21% oxygen) or hypoxia (1% oxygen) for 36 hours. The
chronic exposure to this oxygen tension recapitulates the oxygen
levels found in hypoxic tumours [1] and has been shown to trigger a
full hypoxic response in cell cultures. As a read-out of the genetic
response to hypoxia in these experimental settings, HIF1a protein
levels were analysed. HIF1a is a key transcription factor that, once
stabilized under hypoxia, orchestrates many aspects of the
metabolic adaptation to low oxygen level. As expected, chronic
hypoxia led to HIF1a stabilization and to the induction of HIF1
target genes (Figure 1A). In particular, several glycolytic enzymes
such as glyceraldehyde-3-phosphate dehydrogenase (GAPDH),
phosphoglycerate kinase 1 (PGK1) and lactate dehydrogenase A
(LDHA) were significantly upregulated in hypoxic cells (Figure 1B).
Furthermore, the rate of glucose uptake, measured by the
fluorescent derivative of glucose, 6-[N-(7-nitrobenz-2-oxa-1,3-
diazol-4-yl)amino]-6-deoxyglucose (6NBDG), and the rate of
glucose consumption, were both elevated in hypoxic cells
(Figure 1C–G). In line with these observations, the increased
glycolytic flux was mirrored by an increase in lactate production
under hypoxia (Fig. 1F–G). Importantly, the relevant gene
transcription pattern and lactate secretion in response to chronic
hypoxia were inhibited when HIF1b was efficiently silenced in these
cells, emphasising the role of HIF in long-termmetabolic adaptation
(Figure 1B and H). However, the increase in glucose uptake under
hypoxia was not reversed by HIF silencing, indicating that
bioenergetics needs can also be met by direct biochemical
alterations without long-term genetic adaptation (Figure 1H).
Mitochondrial function under hypoxia
Mitochondria are crucial oxygen sensors, and their function is
linked to several metabolic pathways. Therefore, mitochondrial
function under normoxia and hypoxia was analysed. To overcome
the technical limitations of standard polarography for measuring
oxygen consumption of hypoxic cells, in particular, the requirement
for samples reoxygenation, phosphorescence-quenching oxymetry
was used. This method is compatible with standard fluorescent
spectrometers and it retains sensitivity at low oxygen concentrations.
Therefore, it enabled us for the first time to measure oxygen
consumption of intact hypoxic cells without the need to reoxygenate
the samples, as is commonly done by others (see Figure 2A for a
schematic representation of the experiment). To convert the
fluorescent signals into actual oxygen consumption rates, the probe
was calibrated at different stable levels of dissolved oxygen
(Figure 2B). Since the cells were maintained in sealed ‘‘anaerobic’’
cuvettes during the entire analysis, respiration rate could be
measured across a range of oxygen levels from normoxia to anoxia.
The cells showed a constant rate of oxygen consumption until deep
hypoxia (estimated oxygen concentration below 1%) was reached in
the anaerobic cuvette (Figure 2C). Of note, HIF1a was not yet
stabilized when cells reached acutely low oxygen levels (Figure 2C;
insert), suggesting that HIF does not play a role in the inhibition of
mitochondrial respiration in response to acute hypoxia. Important-
ly, these results demonstrate that cells have the capacity to maintain
constant respiration under a wide range of hypoxic conditions until
oxygen becomes a limiting factor. We next measured the oxygen
consumption rate of cells exposed to chronic hypoxia (36 hours at
1% oxygen). In line with the described above results, hypoxic cells
retained mitochondrial-dependent oxygen consumption (Figure 2D)
which was promptly inhibited by the cytochrome c oxidase
inhibitor, potassium cyanide (KCN) (Figure 2E). However,
respiratory rate of cells continuously grown at 1% oxygen was
significantly below that of normoxic cells (Figure 2E).
Despite the fact that respiration is partially preserved under
hypoxia, other parameters of mitochondrial function may be
affected with important consequences on cellular metabolism. In
particular, the decreased electron flux through the respiratory
chain might cause a change in the ratio between the reduced
(NADH) and oxidized (NAD+) nicotinamide adenine dinucleotide
that may affect the cytosolic levels NAD+ required for glycolysis.
To assess the levels of NADH in intact cells we took advantage of
the spectral characteristic of the molecule, which is fluorescent
when excited by ultra-violet light, while its oxidized form, NAD+,
is not. Since NADH is the major autofluorescent signal present in
cells, confocal real-time imaging of NADH has been widely used
to detect changes in NADH oxidation and as readout of
mitochondrial respiration [15,16]. To properly evaluate the effect
of mitochondrial respiration on NADH levels, cells were incubated
with rotenone, an inhibitor of NADH-ubiquinone oxidoreductase
(Complex I) and with the uncoupler carbonyl cyanide m-
chlorophenylhydrazone (CCCP). In normoxic cells CCCP deplet-
ed mitochondrial NADH due to stimulation of the maximal rate of
NADH-dependent respiration. On the other hand, rotenone, by
blocking NADH oxidation, caused a maximal increase in
mitochondrial autofluorescence (Figure 3A–B). Interestingly,
hypoxic HCT116 cells showed minimal changes of basal NADH
levels and rotenone could still increase NADH levels to that of
rotenone-treated normoxic cells (Figure 3A–B). The response to
CCCP of hypoxic cells was somewhat different than that of
normoxic cells with only partial reduction in NADH levels
(Figure 3A–B). This is in line with the reduced rate of respiration
observed under hypoxia (Figure 2E) as NADH is the major
electron donor to oxygen in the respiratory chain. These results
underline the ongoing complex I-dependent NADH oxidation
under hypoxia that would also explain the mitochondrial-
dependent oxygen consumption under these conditions. In line
with the above, a clear reduction in NAD+/NADH ratio was
observed under hypoxic conditions indicating a more reduced
state of the cells under hypoxia (Figure 3C).
The activity of the respiratory chain is mirrored by the
generation of the mitochondrial membrane potential, the proton
gradient across the inner mitochondrial membrane. Therefore,
normoxic and hypoxic cells were incubated with the mitochondrial
potential-dependent probe tetramethyl rhodamine ethyl ester
(TMRE) together with the mitochondrial potential-independent
probe Mitotracker green (MTG). Using confocal microscopy,
cumulative images of sequential focal sections were acquired and
z-stacks of the whole microscopic field were generated in order to
measure the volume and intensity of the red and green markers.
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Figure 1. Biochemical signature of hypoxic cells. (A) HCT116 cells were exposed to normoxia (21% oxygen) or hypoxia (1% oxygen) for
36 hours and the protein levels of HIF1a and the indicated HIF targets were analysed by western blot. (B) HCT116 cells were transfected with either
control short hairpin RNA (shControl) of shHIF1b and then incubated for 36 hours under normoxia or hypoxia. RNA was extracted and
retrotranscribed to analyse the expression of HIF1b and the indicated HIF target genes by qRT-PCR. Where indicated, HIF transcriptional activity was
inhibited by silencing the HIF transcriptional co-factor HIF1b (shHIF1b). (C–D) Cells were treated as in panel A and were then incubated with 30 mM of
the fluorescent glucose analogue 6-NBDG for 10 minutes prior to analysis by fluorescence-activated cell sorter (FACS). (E–F) The levels of glucose (E)
and lactate (F) in the medium were assessed enzymatically at 36 hours under normoxia or hypoxia. (G) LC-MS was utilized to measure glucose
consumption and lactate production of HCT116 cells incubated for 36 hours under normoxia or hypoxia. (H) Cells were treated as in B and lactate
excretion and glucose consumption was assessed by LC-MS analysis in the medium. Data are normalized to control-transfected cells under normoxia.
Data are presented as means 6 SE (n = 3). HIF1a/b, Hypoxia Inducible Factor 1a/b; PHD3, Prolyl Hydroxylase Domain proteins 3; LDHA, Lactate
Dehydrogenase A; BNIP3, Bcl2 and E1B 19kD Interacting Protein; GAPDH, Glyceraldehyde 3-phosphate dehydrogenase; PDK1, Pyruvate
Dehydrogenase Kinase 1; PGK1, Phosphoglycerate Kinase 1; REDD1, REgulated in Development and DNA damage response protein 1.
doi:10.1371/journal.pone.0024411.g001
Figure 2. Measurement of respiration of hypoxic cells. (A) Schematic representation of the experiment for the assessment of respiration using
an anaerobic cuvette and the oxygen sensor MitoXpress. (B) Fluorescence intensity calibration of MitoXpress at different oxygen tensions required for
quantification of oxygen concentration. (C–D) Representative traces of oxygen consumption of equal amount of cells pre-incubated under normoxia
(C) or hypoxia (D). Cells were analysed for their HIF1a content. Equal amounts of proteins were analysed by western blot and probed for HIF1a and
actin (Inserts). (E) Quantification of oxygen consumption rates of normoxic and hypoxic cells. When indicated, cells were pre-incubated with 1 mM
potassium cyanide for 5 minutes before starting the measurement of oxygen consumption. Data are presented as means 6 SE (n = 3).
doi:10.1371/journal.pone.0024411.g002
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This ratiometric (red/green) quantification was required to reduce
possible artefacts arising from changes in fluorescence emission of
TMRE due to changes in mitochondrial shape and volume rather
than from actual changes in mitochondrial membrane potential.
Representative images were obtained by flattening the z-stack into
a maximum projection image (Figure 3B). To rule out the
possibility that mitochondrial membrane potential was generated
by ATP hydrolysis and proton pumping by ATP synthase working
in reverse, cells were also incubated with oligomycin, the inhibitor
of the Fo subunit of ATP synthase. Our data showed that the
normoxic cells incubated with oligomycin maintained their
mitochondrial potential while, as expected, CCCP completely
depolarized mitochondria (Figure 3B and D). Hypoxic cells
showed a dramatic decrease in mitochondrial potential even in
the absence of oligomycin (Figure 3B, bottom panels), suggesting
that hypoxia triggers a decrease in mitochondrial potential that
cannot be recovered by the reversal of ATP synthase. Subse-
quently, we analysed whether the mitochondrial dysfunction of
hypoxic cells has a functional outcome on ATP levels due to the
lack of mitochondrial membrane potential required for ATP
synthesis. Indeed, hypoxic ATP levels dropped by about 40%
compared to normoxic cells (Figure 3E). Importantly, a further
drop in ATP levels was observed after a short incubation of
hypoxic cells with oligomycin, suggesting that ATP levels of
hypoxic cells are partially maintained by mitochondrial ATP
synthase, despite the low mitochondrial potential.
Metabolomic analysis of hypoxic cells
Oxygen limitation, mitochondrial dysfunction, and the genetic
reprogramming initiated under hypoxia are likely to elicit global
metabolic changes beyond anaerobic glycolysis. To better under-
stand the metabolic signature of hypoxic cells, we performed an
unsupervised endo-metabolomic analysis of normoxic and hypoxic
cells using LC-MS. The total ion current of the different samples
was used as a confirmation for normalized input (Figure S1A). The
metabolomic profile of each experiment is a matrix of 241
Figure 3. Analysis of NADH and mitochondrial membrane potential under hypoxia. (A–B) Representative images (A) and their
quantifications (B) of NADH autofluorescence in normoxic and hypoxic cells left untreated or treated with the indicated drugs (10 mM CCCP or 10 mM
Rotenone). The raw images were converted into ‘‘fire’’ LUT (shown in the top left image) using Image J. Bar = 50 mm. (C) HCT116 cells were incubated
under normoxia or hypoxia for 36 hours and whole cell extracts were assessed enzymatically for NAD+ and NADH levels. (D–E) Representative images
(D) and their quantifications (E) of mitochondrial membrane potential of cells incubated under normoxia or hypoxia. Cells were stained with 10 nM
TMRE and 50 nM MTG for 30 minutes. Cells were then left untreated or pre-incubated with 5 mM oligomycin for 30 minutes or 10 mM CCCP for 2
minutes. A whole cell z-stack was acquired and the maximum projection was used as representative images. Bar = 50 mm.
doi:10.1371/journal.pone.0024411.g003
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annotated and confirmed metabolites (Table S1) in 6 columns (3
hypoxic and 3 normoxic samples). This matrix was subjected to
multivariate statistical analysis. First, data was log(2) transformed in
order to compress the dynamic range of peak intensities (Figure
S1B–C). Importantly, the log(2) transformation did not affect the
clustering of the samples. Principal component analysis (PCA), an
unsupervised multivariate statistical method, was applied to the data
matrix to identify significant clusters in an unsupervised manner.
The PCA showed that the two experimental conditions are clearly
statistically distinguishable (Figure S2A). This suggests that hypoxia
caused an unambiguous change in the cell metabolome underlining
the sensitivity of this unbiased metabolic tool to differentiate
between metabolic states of cells. Due to possible fluctuation of
metabolic status of the cells, a second independent metabolic
experiment was performed and only metabolites that demonstrated
consistent behaviour in both experiments were further evaluated.
The unsupervised clustering analysis identified 99 annotated
metabolites that are different between hypoxia and normoxia
(Table S2). Among them, 45 metabolites showed consistent fold
change of more than 1.5 (increase or decrease) in hypoxia and
changes in 32 of them were statistically significant with a p-value
below 0.05 (Figure 4A, B and Figure S2B). These compounds were
clustered into different metabolic pathways as defined by the
Kyoto Encyclopaedia of Genes and Genomes (KEGG) database.
An enrichment of metabolites which are catabolic intermediates of
proteins and lipids was clearly observed under hypoxia (Figure 4B,
C and Table S2). These metabolites include kynurenine
(tryptophan catabolite), and acyl-carnitine derivatives (fatty acid
catabolites) to name a few. These results suggest that hypoxic
HCT116 cells might rely on catabolic processes to compensate the
energetic defect generated by the impairment of mitochondrial
activity and that cannot be compensated by the increased
glycolytic flux.
An important catabolic process which is known to occur under
hypoxia is autophagy, the process of cell’s self-cannibalism that
maintains nutrient supply under starvation [17,18]. In order to
validate the presence of autophagy in HCT116 cells under hypoxia
we used the autophagic reported –GFP-LC3, which relocates from
the cytosol to the autophagosomes during autophagy and hence
appear more punctated when analysed microscopically [19]. Indeed,
increased autophagosome formation could be clearly observed under
hypoxia in these cells (Figure 5A, B). Importantly, BNIP3, a HIF-
dependent gene that promote autophagy, was found to be
significantly increased in hypoxic HCT116 cells (Figure 1A, B). Of
note, a similar increase in BNIP3 mRNA levels was found in a
transcriptomic study (microarray) of hypoxic HCT116 cells [10].
Since BNIP3 was associated with increased specific autophagy of the
mitochondria (mitophagy) [20] we investigated whether some of the
metabolic changes we observed under hypoxia were due to an active
loss of the mitochondria via mitophagy. However, we could not
identify changes in mitochondria levels in these cells when analysed
either microscopically (Figure 2D) or by the levels of specific
mitochondrial proteins (Figure 5C). Therefore, we concluded that
while autophagy is induced in HCT116 cells after 36 hours under
hypoxia, an accompanied mitochondria-specific elimination process
was not detected and cannot account for the observed metabolic
changes. To further corroborate the importance of this catabolic
process as an integral part of the metabolic adaptation process to
hypoxia, hypoxic cells were incubated with autophagy inhibitors,
Concanamycin A or Bafilomycin A. Inhibition of autophagy resulted
in a dramatic depletion of ATP levels in hypoxic HCT116 cells
(Figure 5D) and in a significant loss of cell viability (Figure 5E).
Discussion
The role of oxygen in the regulation of cellular metabolism has
been widely investigated over more than a century. Initially, the
cellular adaptation to hypoxia was mainly considered as a re-
arrangements of metabolite fluxes as a consequence of respiratory
impairment [21]. The discovery of HIF and of other oxygen-
dependent genes shifted the attention from biochemical to genetic
adaptations to hypoxia. Interestingly, it now appears that
biochemical and genetic changes observed under hypoxia are
intertwined in complex regulatory pathways where metabolites
regulate gene expression and gene expression regulates biochemical
pathways therefore both contributing to the metabolic signature of
hypoxic cells.
Mitochondria are the major oxygen consumers in the cell and
are in the heart of several biochemical pathways involved both
energy production and the generation of anabolic intermediates
required for proliferation. Therefore, changes in mitochondrial
function under hypoxia are likely to contribute to the altered
metabolic profile of cells, making mitochondria important oxygen
sensors. While the genetic reprogramming during hypoxia has
been characterized and many players in this process have been
identified, the contribution of mitochondria to the hypoxic
response is still uncertain. Isolated mitochondria can respire
efficiently even at very low oxygen concentration [22] with a
Km for oxygen of less than 1 mM (,0.1% oxygen saturation),
advocating that mitochondrial metabolism is insensitive to changes
in the physiological range of oxygen tensions. However, bio-
chemical changes such as increased lactate production, alterations
in the redox state of the cells and in ATP/ADP ratio were
demonstrated at oxygen levels at which respiration was unaffected
(i.e. .100 mM) [23,24]. In a possible unifying scenario, it was
proposed that in order to keep mitochondrial respiration constant
until very low oxygen concentration is reached, other parameters
of mitochondrial function, such as NADH oxidation and ATP
production, must constantly be adjusted, thus affecting other
pathways in the cytosol. While NADH and ATP availability are
known to affects glycolytic flux, the effects of oxygen limitation on
cellular metabolism may be wider than simply the induction of
anaerobic glycolysis. In this investigation, we provide a novel
experimental approach to assess the hypoxic signature of cancer
cells by using a combination of biochemistry, real-time imaging
and metabolomics to investigate several unanswered questions
about metabolism of hypoxic cells.
Using phosphorescent-quenching oxymetry, respiration of
normoxic and hypoxic cells was characterised. This technique
allows for the measurement of oxygen consumption of intact
hypoxic cells without the need to reoxygenate the sample. The
sharp transition from an active respiring stage to a non-respiring
stage suggests that cells reach near anoxia before respiration halts,
confirming the capacity of mitochondria to respire at very low
oxygen levels (Figure 2C). Importantly, the rate of respiration of
cells adapted to chronic hypoxia demonstrated that they retain
Figure 4. Metabolomic analysis of hypoxic cells. (A) Heatmaps of annotated metabolites with the same trend (upregulated or downregulated
in hypoxia) in two independent experiments each one performed in triplicates. (B) Fold change variation of the selected metabolites (.1,5 fold).
Significant changes (p,0.05) are indicated with an asterisk. Metabolites were assigned to metabolic pathways according to KEGG database. (C) Pie
chart representation of the metabolic pathways which are significantly changed under hypoxia.
doi:10.1371/journal.pone.0024411.g004
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active respiration though at significantly reduced rate (Figure 2D
and E). These results indicate that in chronically-hypoxic cells,
oxygen consumption is limited even at 1% (,10 mM) oxygen,
concentration which is 10 folds above the reported Km of
mitochondria for oxygen. Changes in respiration at this oxygen
levels might be explained either by changes in the Vmax of
cytochrome c oxidase [25] or by the effects of HIF on the
composition of the respiratory chain subunits or on substrates
availability to mitochondria [5,10]. In addition, the decrease in
respiration under hypoxia was linked to increased mitophagy [20];
however, confocal microscopy did not reveal gross changes in the
mitochondrial content under hypoxia (Figure 3).
To overcome a bioenergetic deficit, metabolic alterations may
be exploited by the hypoxic cell. Indeed, metabolomic analysis was
demonstrated to be an effective tool to characterise the metabolic
signature of hypoxic cells. PCA showed that distinct metabolic
signatures of normoxic and hypoxic cells could be defined. The
top-rank compounds (p-value ,0.05 and fold change .1.5) found
in hypoxic cell line showed extensive alterations of amino acids
and fatty acid/phospholipids metabolism (Table S2). Among
these, we observed an increase in the amino acids threonine,
proline and glutamine. An increase in intracellular amino acids
under hypoxia may be attributed to several possibilities: An
increase in amino acid uptake and/or a decrease in protein
synthesis, a phenomenon which is considered to be part of the
metabolic adaptation to hypoxia where ATP-consuming reactions,
like protein synthesis, are dramatically decreased [26]. Another
possibility, which is not mutually exclusive, is that during hypoxia
cells undergo protein catabolism in order to provide the cells with
metabolic support and the increase in macroautophagy under
hypoxia may provide an explanation to this observation [27]. In
support of this, degradation products of amino acids were a
Figure 5. The role of autophagy in hypoxia. (A–B) representative images (A) and their quantifications (B) of cells stably expressing the
autophagy reported GFP-LC3. As positive control cells were incubated with bafilomycin A, an inhibitor of the lysosomal functions which lead to the
increased steady-state levels of autophagosomes. (C) The protein levels of HIF1a and the mitochondrial proteins OPA1 and VDAC1 in cells incubated
under normoxia or hypoxia was assessed by western blot analysis. Actin was used as a loading control. (D) ATP levels were analysed in cells exposed
to normoxia or hypoxia. Where indicated, cells were pre-incubated for 2 hours with 5 mM oligomycin (ATP synthase inhibitor) or 1 nM concanamycin
A (autophagy inhibitor). Data are presented as means 6 SE (n = 9). (E) Viability was measured in cells exposed to normoxia or hypoxia. Where
indicated, cells were pre-incubated for 8 hours with 1 nM concanamycin A or 100 nM bafilomycin A. Cell viability was then assessed by propidium
iodide exclusion by FACS. Data are presented as means 6 SE (n = 9).
doi:10.1371/journal.pone.0024411.g005
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significant part of the hypoxic signature (Table S2) and increase
autophagy was observed under hypoxic conditions (Figure 5A, B).
Fatty acid and phospholipid metabolic pathways are a second
important metabolic signature of hypoxic cells (Figure 4). A
significant increase in acyl-carnitines, such as butyl and valeryl
carnitine, was identified in these cells. It is known that fatty acid
oxidation for energy purposes accounts for a significant proportion
of oxygen consumption in cells [28]. Therefore, the catabolic
process of amino acids and fatty acid may be required to sustain
the observed oxidative phosphorylation in hypoxic cells – freeing
more glucose to be converted to lactate (and with it the recycling of
cytosolic NAD+) and hence supporting faster glycolytic rate. In line
with that, a dramatic reduction in ATP was observed in hypoxic
cells under conditions where autophagy was inhibited (Figure 5D).
Interestingly, acyl-carnitines themselves facilitate the autophagic
process [29,30].
This hypoxic metabolic profiling revealed a shift in balance
between anabolic and catabolic processes that is likely to have
important survival consequences. Therefore, unbalancing the
anabolic/catabolic ratio under hypoxia, by either stimulating
anabolism (e.g. by inhibiting AMPK) and/or inhibiting catabolism
(e.g. blocking macroautophagy) is a possible strategy for
specifically targeting hypoxic cells in tumours. In support to this
hypothesis, the incubation with inhibitors of macroauthophagy
such as concanamycin A and bafilomycin A caused significant cell
death of hypoxic cells (Figure 4D). Taken together, our results
underline the importance of combining biochemistry and
metabolomics analyses to identify adaptation to stress induced
by hypoxia. Importantly, the finding of specific adaptive pathways
that operate under hypoxia might offer new therapeutic
approaches for cancer treatment by targeting the metabolic
pathways required for the survival of hypoxic tumour cells and
hence sparing normal cells, which are rarely exposed to hypoxia.
Materials and Methods
Detailed protocols are available on Supporting Information
online in the file Methods S1.
Supporting Information
Figure S1 Metabolomic analysis of hypoxic cells. (A)
Total ion current of cell extracts obtained from hypoxic or
normoxic HCT116 submitted to LC-MS analysis. (B–C) Histo-
grams of the distribution of m/z of metabolites before (B) and after
(C) log2 transformation obtained from LC-MS analysis.
(TIF)
Figure S2 Metabolic signature hypoxic cells. (A) Spectral
clustering of cells under normoxia or hypoxia. (B) Heatmaps of
annotated metabolites with the same trend (upregulated or
downregulated in hypoxia) using the indicated restrictions for fold
change (f.c.) and p-value.
(TIF)
Table S1 Metabolomic database. Database of annotated
compounds detectable by Orbitrap Exactive LC-MS by negative
and positive ion mode. RT= retention time.
(XLS)
Table S2 Metabolic signature of hypoxic cells. List of
metabolites changed upon hypoxia. Metabolites with a cut off of
fold change of .1.5 or p-value ,0.05 are indicated with an
asterisk. The metabolic pathways (derived from KEGG) which
each metabolite belongs to are indicated. Metabolic pathway
coding are as follow: A: amino acid, C: carbohydrate, E: creatine,
F: fatty acid/phospholipids, G: glutathione, H: heme, N:
neurotransmitter, Nu: nucleotide, O: oxidative phosphorylation,
P: pentose phosphate, T: TCA cycle, V: vitamins.
(XLS)
Methods S1 Detailed description of the materials and
methods utilized in the manuscript.
(DOCX)
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